Are Medications Useful in Treating Behavioural Problems in Children with Autism?

While medications can be useful in managing behavioural problems in children with autism, they are not without risks

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterised by challenges in communication, social interaction, and behaviour. Behavioural problems, such as aggression, hyperactivity, irritability, and self-injury, are common in children with autism. These behaviours can significantly impact a child's quality of life and place a burden on families and caregivers. Medications are often considered as a treatment option for managing these behavioural problems. However, the use of medications in children with autism is complex, and their effectiveness and appropriateness must be carefully weighed against potential risks.

Understanding the Role of Medications

Medications are not a cure for autism. Instead, they manage specific symptoms or co-occurring conditions that may exacerbate behavioural problems. For example, children with autism often have comorbid conditions such as anxiety, attention-deficit/hyperactivity disorder (ADHD), or epilepsy, which can contribute to challenging behaviours. In such cases, medications may be prescribed to address these underlying conditions, potentially leading to improvements in behaviour.

The most commonly prescribed medications for children with autism include antipsychotics, stimulants, selective serotonin reuptake inhibitors (SSRIs), and mood stabilisers. Each class of medication targets different symptoms:

Antipsychotics: Medications like risperidone and aripiprazole are often used to reduce irritability, aggression, and self-injurious behaviour in children with autism. These medications have been shown to be effective in managing these symptoms, but they also carry the risk of side effects, such as weight gain, sedation, and metabolic changes.

Stimulants: Drugs like methylphenidate, commonly used to treat ADHD, can help reduce hyperactivity and impulsivity in children with autism. While stimulants can be effective, they may also cause side effects such as decreased appetite, insomnia, and increased anxiety.

SSRIs: These medications, typically used to treat anxiety and depression, may be prescribed to children with autism who exhibit anxiety or obsessive-compulsive behaviours. However, the evidence for their effectiveness in autism is mixed, and they can have side effects like agitation and gastrointestinal issues.

Mood Stabilizers: Medications such as valproic acid and lamotrigine are sometimes used to manage mood swings and aggression. While they may be helpful for some children, they also come with risks, including potential liver toxicity and other serious side effects.

Weighing the Benefits and Risks

The decision to use medications for treating behavioural problems in children with autism should be made on a case-by-case basis, considering the severity of symptoms, the impact on the child’s quality of life, and the potential benefits and risks of treatment. Any use of medication must be consulted with the necessary professionals (eg. psychologist/psychiatrist, depending on your area), who are qualified to prescribe the appropriate medication. Non-pharmacological interventions, such as behavioural therapy, speech therapy, and occupational therapy, should be considered first-line treatments, with medications used as an adjunct when necessary.

It is crucial for parents and caregivers to work closely with healthcare professionals to monitor the child's response to medication and to adjust the treatment plan as needed. Regular follow-up appointments are essential to assess the effectiveness of the medication and to manage any side effects that may arise.

While medications can be useful in managing behavioural problems in children with autism, they are not without risks. The decision to use medication should be made with caution, and it should always be part of a comprehensive treatment plan that includes behavioural and therapeutic interventions. Ongoing research is needed to better understand the long-term effects of these medications and to develop more targeted treatments that can address the unique challenges faced by children with autism.

Written by: Sharon

References

McDougle, C. J., Scahill, L., Aman, M. G., McCracken, J. T., Tierney, E., Arnold, L. E., ... & Vitiello, B. (2005). Risperidone for the core symptom domains of autism: results from the study by the autism network of the Research Units on Pediatric Psychopharmacology. American Journal of Psychiatry, 162(6), 1142-1148.

Coury, D. L. (2010). Medical treatment of autism spectrum disorders. Current Opinion in Neurology, 23(2), 131-136.

Hollander, E., Phillips, A. T., & Yeh, C. C. (2003). Targeted treatments for symptom domains in child and adolescent autism. The Lancet, 362(9390), 732-734.

King, B. H., & Bostic, J. Q. (2006). An update on pharmacologic treatments for autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America, 15(1), 161-175.

Posey, D. J., & McDougle, C. J. (2001). The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders. Harvard Review of Psychiatry, 9(4), 195-211.

Raising Children Network. (n.d.). Medicines for autistic children and teenagers [Photograph]. Raising Children Network. https://raisingchildren.net.au/autism/therapies-services/therapies-interventions/medications-asd